Raben David bought BCAX
November 24, 2025 · Form 4 insider transaction
Raben David bought 5,500 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $20.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,500
Price
$3.79
Total value
$20.8K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 24, 2025
Filing dateNovember 25, 2025
Shares owned after40,997
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.